AccScience Publishing / BH / Volume 2 / Issue 2 / DOI: 10.36922/bh.2190
CASE REPORT

Patent foramen ovale closure in a patient with extensive lipomatous hypertrophy of the septum secundum: A case report

Sergey Terekhin1 Dimtry Shchekochikhin1 Alexandr G. Osiev2 Eustaquio Maria Onorato3*
Show Less
1 Department of Cardiology, Ilynskaya Hospital JSC, Moscow, Russia
2 Department of Endovascular Cardiology, JSC Hospitals Medsi, Moscow, Russia
3 Department of Cardiology University Hospital, I.R.C.C.S. Ospedale Galeazzi - Sant’Ambrogio, Milan, Italy
Brain & Heart 2024, 2(2), 2190 https://doi.org/10.36922/bh.2190
Submitted: 6 November 2023 | Accepted: 29 December 2023 | Published: 2 May 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Abstract

Lipomatous hypertrophy of the septum secundum (LHSS) is a benign disorder characterized by the accumulation of fat in the interatrial septum, presenting with an hourglass appearance that spares the fossa ovalis on echocardiography. Typically asymptomatic, LHSS is often incidentally detected through two-dimensional transthoracic echocardiography/transesophageal echocardiography, computed tomography, and cardiac magnetic resonance imaging. It primarily affects elderly and obese individuals, with a higher prevalence among females, and may cause atrial arrhythmias, syncope, and heart failure. Transcatheter closure of patent foramen ovale (PFO) associated with LHSS has traditionally posed challenges due to the lack of specifically designed devices and the risk of suboptimal results. Our case report details the off-label implantation of a flexible atrial septal defect closure device for a PFO closure in an elderly patient presenting with an embolic stroke of undetermined source, severe kyphosis, platypnea-orthodeoxia syndrome, and a large LHSS. In addition, strategies adopted to enhance the success of percutaneous closure are discussed.

Keywords
Lipomatous hypertrophy of the septum secundum
Patent foramen ovale
Atrial septal defect
Platypnea-orthodeoxia syndrome
Thoracic kyphosis
Transcatheter closure
Funding
None.
References
  1. De Vecchis R, Baldi C, Ariano C. Platypnea-orthodeoxia syndrome: Multiple pathophysiological interpretations of a clinical picture primarily consisting of orthostatic dyspnea. J Clin Med. 2016;5:85. doi: 10.3390/jcm5100085

 

  1. Agrawal A, Palkar A, Talwar A. The multiple dimensions of platypnea-orthodeoxia syndrome: A review. Respir Med. 2017;129:31-38. doi: 10.1016/j.rmed.2017.05.016

 

  1. Prior JT. Lipomatous hypertrophy of cardiac interatrial septum. A lesion resembling hibernoma, lipoblastomatosis and infiltrating lipoma. Arch Pathol. 1964;78:11-15.

 

  1. Laura DM, Donnino R, Kim EE, Benenstein R, Freedberg RS, Saric M. Lipomatous atrial septal hypertrophy: A review of its anatomy, pathophysiology, multimodality imaging, and relevance to percutaneous interventions. J Am Soc Echocardiogr. 2016;29:717-723. doi: 10.1016/j.echo.2016.04.014

 

  1. Pochis WT, Saeian K, Sagar KB. Usefulness of transesophageal echocardiography in diagnosing lipomatous hypertrophy of the atrial septum with comparison to transthoracic echocardiography. Am J Cardiol. 1992;70:396-398. doi: 10.1016/0002-9149(92)90629-d

 

  1. Patsia L, Lartsuliani K, Intskirveli N, Ratiani L. Lipomatous hypertrophy of the interatrial septum - a benign heart anomaly causing unexpected problem in electrophysiology (case report). Georgian Med News. 2021;318:72-74.

 

  1. Xanthos T, Giannakopoulos N, Papadimitriou L. Lipomatous hypertrophy of the interatrial septum: A pathological and clinical approach. Int J Cardiol. 2007;121:4-8. doi: 10.1016/j.ijcard.2006.11.150

 

  1. Cheezum MK, Jezior MR, Carbonaro S, Villines TC. Lipomatous hypertrophy presenting as superior vena cava syndrome. J Cardiovasc Comput Tomogr. 2014;8:250-251. doi: 10.1016/j.jcct.2014.04.005

 

  1. Arbarello P, Maiese A, Bolino G. Case study of sudden cardiac death caused by lypomatous hypertrophy of the interatrial septum. Med Leg J. 2012;80:102-104. doi: 10.1258/mlj.2012.012012

 

  1. Fernandes FH, do Amaral LV, Borges PA, de Almeida e França VE, Masson Silva JB, Gardenghi G. Patent foramen ovale closure with prosthesis for occlusion of atrial septal defect in lipomatous hypertrophy of atrial septum. Report of two cases. J Transcat Intervent. 2020;28:eA20200003. doi: 10.31160/JOTCI202028A20200003

 

  1. Takafuji H, Obunai K, Kato N, Honda M, Watanabe H. Lipomatous atrial septal hypertrophy and atrial septal defect with rim deficiency. JACC Cardiovasc Interv. 2022;15(3):e31-e33. doi: 10.1016/j.jcin.2021.09.040

 

  1. Seemann A, Dorman S, Juliard JM. Platypnoea-orthodeoxia syndrome due to a patent foramen oval with marked lipomatous hypertrophy. Arch Cardiovasc Dis. 2011;104:261-262. doi: 10.1016/j.acvd.2010.10.010

 

  1. Lin CH, Balzer DT, Lasala JM. Defect closure in the lipomatous hypertrophied atrial septum with the Amplatzer muscular ventricular septal defect closure device: A case series. Catheter Cardiovasc Interv. 2011;78:102-107. doi: 10.1002/ccd.22858
Conflict of interest
Eustaquio Maria Onorato is a consultant for Occlutech. The remaining authors declare no conflicts of interest.
Share
Back to top
Brain & Heart, Electronic ISSN: 2972-4139 Published by AccScience Publishing